vTv Therapeutics
VTVT | NASDAQ
$17.69
-$2.00 (-10.16%)
At close: Nov 16, 2026, 4:00 PM ET
$17.69
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-10.16%
(1D)No price chart data available for 1D timeframe.
Rating
33
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #715/1021 (Top 70%)
Key Statistics
Market Data
Market Cap $69.95M
1D Range
17.28 19.41
52W Range
17.28 42.72
Valuation (TTM)
PE -
PB 1.00
EV/EBITDA -1.83
Valuation (NTM)
Forward PE N/A
Forward PEG -11.19
Price Target $42.00
Cash Flow
FCF Yield -31.1%
SBC Adj. FCF Yield -39.8%
SBC Impact -28.1%
Margins
Gross Margin 100.0%
Operating Margin 3.9%
FCF Margin -59.0%
Growth (CAGR)
Revenue 3Y | 5Y 1499.6% |
28.8%
Dil EPS 3Y | 5Y 86.6% |
51.8%
FCF 3Y | 5Y 3.8% |
-5.6%
Returns
ROA -9.8%
ROE -10.2%
ROIC -15.3%
Financial Health
Net Cash
$77.16M
Current Ratio 11.19
Interest Coverage -10,978.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipel...
Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Jul 30, 2015
Website www.vtvtherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$42.00
Upside
+137.42%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove VTVT